The independent API company of choice for pharmaceutical industry leaders is located in a special ecological industrial zone in southern Israel. The company offers a variety of tailor-made solutions necessary to manufacture premium APIs. It is looking for additional partners to develop and market products globally either through outsourcing or manufacturing agreements. Also a commercial agency or distribution agreement would be considered to expand sales to markets not already exhausted.
For over 33 years the world-class independent developer and manufacturer of differentiated Active Pharmaceutical Ingredients. A trusted name in the pharmaceutical industry, is attentive to be a partner that is in tune with the results required to better support the requirements of its' customers and partner(s). Founded in Israel in 1987, serving more than 250 customers in 50 countries, it employs a highly skilled team with all the expertise you require to advance products to market, now, and well into the future. Our cGMP-compliant facility is a first-class operation with over 30 years of exceptional regulatory track record with leading global authorities such as USFDA, EUEMA, PMDA, TGA, KFDA, ANVISA and COFEPRIS, while meeting the highest safety and environmental responsibility standards. The company values its experts in complex chemistry, innovative process development, crystalline forms and particle design and offer customized solutions to meet individual customer requirements including full spectrum API CDMO services from pre-clinical grams to multi-ton commercial scale. The company is looking for a commercial agent or pharmaceutical distributor to acquire new markets to the company to add to the existing markets. The company is interested also in a manufacturing agreement with companies in the pharmaceutical industry who are seeking development of APIs. Additionally, an outsourcing agreement can be made for companies in the same industry who are seeking to outsource their production.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
The Israeli manufacture is seeking for an agent or distributor active in the pharmaceutical industry and with a successful background to represent the company's active portfolio of active APIs to targeted markets. The aim is to acquire new markets where the company is not active, and to expand the sales of the company. The target markets will be discussed further with inquirers. The Israeli company is seeking a manufacturing agreement for APIs that a pharmaceutical company may require for their clinical development programs. The manufacture also offers custom development of a certain API to meet the desired outcome and need of the end product. The Israeli company is seeking a outsourcing agreement for pharmaceutical companies currently manufacturing APIs, who are looking to outsource their production of existing API manufacturing process.
Stage of Development:
Already on the market
Comments Regarding Stage of Development:
37 commercial APIs and 5 commercial FDFs currently sold to more than 250 generic and branded pharmaceutical customers in over 50 countries. The company also have a wide range of pipeline products that are currently under development
Patent(s) applied for but not yet granted,Patents granted